Friday, August 27, 2010

Prana Biotech receives patent for selected 8-hydroxyquinoline

Prana Biotech which is an Australian company engaged in biotechnology field received a grant of composition of matter patent for selected 8-hydroxyquinoline compounds from US Patent office. After the extension form the USPTO, the expiry of this patent is 21 December 2025 and it may be further get extension as per the patent term extension if will be granted.

For full story, Click here

No comments:

Post a Comment